Physician profile
Barry Waters
NPI 1144227927
$7,588.46
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,020 · 2020: $2,707 · 2021: $1,539 · 2022: $323.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,774.19 | 2019-2021 | |
| Abbvie INC. | $834.03 | 2019-2022 | |
| Lilly USA, LLC | $610.48 | 2019-2022 | |
| Pfizer INC. | $562.25 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $526.00 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $451.53 | 2019-2021 | |
| Ucb, INC. | $387.68 | 2019-2021 | |
| Janssen Biotech, INC. | $350.25 | 2019-2021 | |
| Glaxosmithkline, LLC. | $330.71 | 2019-2021 | |
| Horizon Therapeutics Plc | $254.23 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $242.19 | 2019 | |
| Celgene Corporation | $183.75 | 2019 | |
| Genzyme Corporation | $172.93 | 2019-2020 | |
| Radius Health, INC. | $162.34 | 2019-2021 | |
| Genentech USA, INC. | $145.04 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $137.19 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $134.71 | 2020 | |
| Sanofi-Aventis U.S. LLC | $116.34 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $58.88 | 2020-2021 | |
| Medexus Pharma, INC. | $56.34 | 2019 | |
| Pacira Therapeutics, INC. | $48.72 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $16.73 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $16.35 | 2021 | |
| Merck Sharp & Dohme LLC | $15.60 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.